nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.065	0.127	CbGbCtD
Capecitabine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0594	0.116	CbGbCtD
Capecitabine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0553	0.108	CbGbCtD
Capecitabine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.047	0.0916	CbGbCtD
Capecitabine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.047	0.0916	CbGbCtD
Capecitabine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0434	0.0845	CbGbCtD
Capecitabine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0419	0.0816	CbGbCtD
Capecitabine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0383	0.0747	CbGbCtD
Capecitabine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0356	0.0694	CbGbCtD
Capecitabine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0341	0.0665	CbGbCtD
Capecitabine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0241	0.0469	CbGbCtD
Capecitabine—CYP2C9—Losartan—type 2 diabetes mellitus	0.022	0.0429	CbGbCtD
Capecitabine—TYMP—endothelium—type 2 diabetes mellitus	0.00446	0.11	CbGeAlD
Capecitabine—DPYD—nephron tubule—type 2 diabetes mellitus	0.00353	0.0872	CbGeAlD
Capecitabine—DPYD—pancreas—type 2 diabetes mellitus	0.00308	0.0761	CbGeAlD
Capecitabine—DPYD—cortex of kidney—type 2 diabetes mellitus	0.00302	0.0746	CbGeAlD
Capecitabine—DPYD—adipose tissue—type 2 diabetes mellitus	0.0028	0.0691	CbGeAlD
Capecitabine—CDA—adipose tissue—type 2 diabetes mellitus	0.00269	0.0665	CbGeAlD
Capecitabine—DPYD—liver—type 2 diabetes mellitus	0.00196	0.0484	CbGeAlD
Capecitabine—CDA—liver—type 2 diabetes mellitus	0.00189	0.0466	CbGeAlD
Capecitabine—TYMS—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00185	1	CbGdCrCtD
Capecitabine—TYMP—cardiovascular system—type 2 diabetes mellitus	0.00184	0.0454	CbGeAlD
Capecitabine—TYMS—nephron tubule—type 2 diabetes mellitus	0.00175	0.0434	CbGeAlD
Capecitabine—TYMP—cortex of kidney—type 2 diabetes mellitus	0.00175	0.0432	CbGeAlD
Capecitabine—TYMP—adipose tissue—type 2 diabetes mellitus	0.00162	0.04	CbGeAlD
Capecitabine—CES1—cardiovascular system—type 2 diabetes mellitus	0.00159	0.0392	CbGeAlD
Capecitabine—TYMS—cortex of kidney—type 2 diabetes mellitus	0.0015	0.0371	CbGeAlD
Capecitabine—CES1—adipose tissue—type 2 diabetes mellitus	0.0014	0.0345	CbGeAlD
Capecitabine—TYMS—adipose tissue—type 2 diabetes mellitus	0.00139	0.0343	CbGeAlD
Capecitabine—TYMP—liver—type 2 diabetes mellitus	0.00114	0.0281	CbGeAlD
Capecitabine—CES1—liver—type 2 diabetes mellitus	0.000981	0.0242	CbGeAlD
Capecitabine—TYMS—liver—type 2 diabetes mellitus	0.000975	0.0241	CbGeAlD
Capecitabine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000688	0.017	CbGeAlD
Capecitabine—CYP2C9—liver—type 2 diabetes mellitus	0.000426	0.0105	CbGeAlD
Capecitabine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.16e-05	0.000278	CcSEcCtD
Capecitabine—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.14e-05	0.000278	CcSEcCtD
Capecitabine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.13e-05	0.000277	CcSEcCtD
Capecitabine—Chest pain—Irbesartan—type 2 diabetes mellitus	9.12e-05	0.000277	CcSEcCtD
Capecitabine—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.12e-05	0.000277	CcSEcCtD
Capecitabine—Myalgia—Irbesartan—type 2 diabetes mellitus	9.12e-05	0.000277	CcSEcCtD
Capecitabine—Shock—Metformin—type 2 diabetes mellitus	9.12e-05	0.000277	CcSEcCtD
Capecitabine—Insomnia—Orlistat—type 2 diabetes mellitus	9.09e-05	0.000276	CcSEcCtD
Capecitabine—Malaise—Losartan—type 2 diabetes mellitus	9.09e-05	0.000276	CcSEcCtD
Capecitabine—Anxiety—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000276	CcSEcCtD
Capecitabine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.09e-05	0.000276	CcSEcCtD
Capecitabine—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.09e-05	0.000276	CcSEcCtD
Capecitabine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.07e-05	0.000276	CcSEcCtD
Capecitabine—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.07e-05	0.000276	CcSEcCtD
Capecitabine—Vertigo—Losartan—type 2 diabetes mellitus	9.06e-05	0.000275	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	9.06e-05	0.000275	CcSEcCtD
Capecitabine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.06e-05	0.000275	CcSEcCtD
Capecitabine—Syncope—Losartan—type 2 diabetes mellitus	9.04e-05	0.000275	CcSEcCtD
Capecitabine—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.03e-05	0.000274	CcSEcCtD
Capecitabine—Leukopenia—Losartan—type 2 diabetes mellitus	9.03e-05	0.000274	CcSEcCtD
Capecitabine—Discomfort—Irbesartan—type 2 diabetes mellitus	9.01e-05	0.000274	CcSEcCtD
Capecitabine—Skin disorder—Metformin—type 2 diabetes mellitus	9e-05	0.000274	CcSEcCtD
Capecitabine—Immune system disorder—Ramipril—type 2 diabetes mellitus	8.97e-05	0.000273	CcSEcCtD
Capecitabine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.96e-05	0.000272	CcSEcCtD
Capecitabine—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.96e-05	0.000272	CcSEcCtD
Capecitabine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	8.95e-05	0.000272	CcSEcCtD
Capecitabine—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.92e-05	0.000271	CcSEcCtD
Capecitabine—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.92e-05	0.000271	CcSEcCtD
Capecitabine—Palpitations—Losartan—type 2 diabetes mellitus	8.91e-05	0.000271	CcSEcCtD
Capecitabine—Nausea—Glimepiride—type 2 diabetes mellitus	8.88e-05	0.00027	CcSEcCtD
Capecitabine—Arrhythmia—Ramipril—type 2 diabetes mellitus	8.87e-05	0.00027	CcSEcCtD
Capecitabine—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.86e-05	0.000269	CcSEcCtD
Capecitabine—Nausea—Sitagliptin—type 2 diabetes mellitus	8.86e-05	0.000269	CcSEcCtD
Capecitabine—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.85e-05	0.000269	CcSEcCtD
Capecitabine—Asthenia—Glyburide—type 2 diabetes mellitus	8.85e-05	0.000269	CcSEcCtD
Capecitabine—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.85e-05	0.000269	CcSEcCtD
Capecitabine—Anorexia—Metformin—type 2 diabetes mellitus	8.83e-05	0.000268	CcSEcCtD
Capecitabine—Cough—Losartan—type 2 diabetes mellitus	8.8e-05	0.000267	CcSEcCtD
Capecitabine—Urticaria—Gliclazide—type 2 diabetes mellitus	8.8e-05	0.000267	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.79e-05	0.000267	CcSEcCtD
Capecitabine—Alopecia—Ramipril—type 2 diabetes mellitus	8.78e-05	0.000267	CcSEcCtD
Capecitabine—Fatigue—Valsartan—type 2 diabetes mellitus	8.77e-05	0.000267	CcSEcCtD
Capecitabine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.76e-05	0.000266	CcSEcCtD
Capecitabine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.76e-05	0.000266	CcSEcCtD
Capecitabine—Oedema—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.000266	CcSEcCtD
Capecitabine—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.74e-05	0.000266	CcSEcCtD
Capecitabine—Pruritus—Glyburide—type 2 diabetes mellitus	8.73e-05	0.000265	CcSEcCtD
Capecitabine—Mental disorder—Ramipril—type 2 diabetes mellitus	8.7e-05	0.000264	CcSEcCtD
Capecitabine—Constipation—Valsartan—type 2 diabetes mellitus	8.7e-05	0.000264	CcSEcCtD
Capecitabine—Infection—Irbesartan—type 2 diabetes mellitus	8.69e-05	0.000264	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.68e-05	0.000264	CcSEcCtD
Capecitabine—Fatigue—Orlistat—type 2 diabetes mellitus	8.67e-05	0.000263	CcSEcCtD
Capecitabine—Hypotension—Metformin—type 2 diabetes mellitus	8.66e-05	0.000263	CcSEcCtD
Capecitabine—Malnutrition—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000263	CcSEcCtD
Capecitabine—Erythema—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000263	CcSEcCtD
Capecitabine—Shock—Irbesartan—type 2 diabetes mellitus	8.6e-05	0.000261	CcSEcCtD
Capecitabine—Pain—Orlistat—type 2 diabetes mellitus	8.6e-05	0.000261	CcSEcCtD
Capecitabine—Arthralgia—Losartan—type 2 diabetes mellitus	8.59e-05	0.000261	CcSEcCtD
Capecitabine—Chest pain—Losartan—type 2 diabetes mellitus	8.59e-05	0.000261	CcSEcCtD
Capecitabine—Myalgia—Losartan—type 2 diabetes mellitus	8.59e-05	0.000261	CcSEcCtD
Capecitabine—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.58e-05	0.000261	CcSEcCtD
Capecitabine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.58e-05	0.000261	CcSEcCtD
Capecitabine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	8.56e-05	0.00026	CcSEcCtD
Capecitabine—Anxiety—Losartan—type 2 diabetes mellitus	8.56e-05	0.00026	CcSEcCtD
Capecitabine—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.53e-05	0.000259	CcSEcCtD
Capecitabine—Rash—Bromocriptine—type 2 diabetes mellitus	8.51e-05	0.000259	CcSEcCtD
Capecitabine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.5e-05	0.000258	CcSEcCtD
Capecitabine—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.49e-05	0.000258	CcSEcCtD
Capecitabine—Discomfort—Losartan—type 2 diabetes mellitus	8.48e-05	0.000258	CcSEcCtD
Capecitabine—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.47e-05	0.000257	CcSEcCtD
Capecitabine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.45e-05	0.000257	CcSEcCtD
Capecitabine—Headache—Bromocriptine—type 2 diabetes mellitus	8.45e-05	0.000257	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.44e-05	0.000257	CcSEcCtD
Capecitabine—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.44e-05	0.000256	CcSEcCtD
Capecitabine—Dry mouth—Losartan—type 2 diabetes mellitus	8.4e-05	0.000255	CcSEcCtD
Capecitabine—Anorexia—Irbesartan—type 2 diabetes mellitus	8.34e-05	0.000253	CcSEcCtD
Capecitabine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.32e-05	0.000253	CcSEcCtD
Capecitabine—Paraesthesia—Metformin—type 2 diabetes mellitus	8.32e-05	0.000253	CcSEcCtD
Capecitabine—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000253	CcSEcCtD
Capecitabine—Confusional state—Losartan—type 2 diabetes mellitus	8.3e-05	0.000252	CcSEcCtD
Capecitabine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.29e-05	0.000252	CcSEcCtD
Capecitabine—Dyspnoea—Metformin—type 2 diabetes mellitus	8.26e-05	0.000251	CcSEcCtD
Capecitabine—Oedema—Losartan—type 2 diabetes mellitus	8.23e-05	0.00025	CcSEcCtD
Capecitabine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.22e-05	0.00025	CcSEcCtD
Capecitabine—Infection—Losartan—type 2 diabetes mellitus	8.18e-05	0.000248	CcSEcCtD
Capecitabine—Hypotension—Irbesartan—type 2 diabetes mellitus	8.17e-05	0.000248	CcSEcCtD
Capecitabine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.16e-05	0.000248	CcSEcCtD
Capecitabine—Dyspepsia—Metformin—type 2 diabetes mellitus	8.16e-05	0.000248	CcSEcCtD
Capecitabine—Tremor—Ramipril—type 2 diabetes mellitus	8.1e-05	0.000246	CcSEcCtD
Capecitabine—Shock—Losartan—type 2 diabetes mellitus	8.1e-05	0.000246	CcSEcCtD
Capecitabine—Urticaria—Valsartan—type 2 diabetes mellitus	8.08e-05	0.000246	CcSEcCtD
Capecitabine—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.07e-05	0.000245	CcSEcCtD
Capecitabine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.06e-05	0.000245	CcSEcCtD
Capecitabine—Decreased appetite—Metformin—type 2 diabetes mellitus	8.06e-05	0.000245	CcSEcCtD
Capecitabine—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.04e-05	0.000244	CcSEcCtD
Capecitabine—Tachycardia—Losartan—type 2 diabetes mellitus	8.03e-05	0.000244	CcSEcCtD
Capecitabine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.02e-05	0.000244	CcSEcCtD
Capecitabine—Nausea—Bromocriptine—type 2 diabetes mellitus	8.01e-05	0.000244	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8e-05	0.000243	CcSEcCtD
Capecitabine—Fatigue—Metformin—type 2 diabetes mellitus	7.99e-05	0.000243	CcSEcCtD
Capecitabine—Urticaria—Orlistat—type 2 diabetes mellitus	7.99e-05	0.000243	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.000242	CcSEcCtD
Capecitabine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.96e-05	0.000242	CcSEcCtD
Capecitabine—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.95e-05	0.000242	CcSEcCtD
Capecitabine—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.95e-05	0.000242	CcSEcCtD
Capecitabine—Asthenia—Gliclazide—type 2 diabetes mellitus	7.95e-05	0.000241	CcSEcCtD
Capecitabine—Constipation—Metformin—type 2 diabetes mellitus	7.92e-05	0.000241	CcSEcCtD
Capecitabine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.85e-05	0.000239	CcSEcCtD
Capecitabine—Anorexia—Losartan—type 2 diabetes mellitus	7.84e-05	0.000238	CcSEcCtD
Capecitabine—Vomiting—Glyburide—type 2 diabetes mellitus	7.84e-05	0.000238	CcSEcCtD
Capecitabine—Pruritus—Gliclazide—type 2 diabetes mellitus	7.84e-05	0.000238	CcSEcCtD
Capecitabine—Malaise—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000237	CcSEcCtD
Capecitabine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.8e-05	0.000237	CcSEcCtD
Capecitabine—Rash—Glyburide—type 2 diabetes mellitus	7.78e-05	0.000236	CcSEcCtD
Capecitabine—Dermatitis—Glyburide—type 2 diabetes mellitus	7.77e-05	0.000236	CcSEcCtD
Capecitabine—Vertigo—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000236	CcSEcCtD
Capecitabine—Syncope—Ramipril—type 2 diabetes mellitus	7.75e-05	0.000236	CcSEcCtD
Capecitabine—Leukopenia—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000235	CcSEcCtD
Capecitabine—Headache—Glyburide—type 2 diabetes mellitus	7.73e-05	0.000235	CcSEcCtD
Capecitabine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.7e-05	0.000234	CcSEcCtD
Capecitabine—Hypotension—Losartan—type 2 diabetes mellitus	7.69e-05	0.000234	CcSEcCtD
Capecitabine—Palpitations—Ramipril—type 2 diabetes mellitus	7.64e-05	0.000232	CcSEcCtD
Capecitabine—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.64e-05	0.000232	CcSEcCtD
Capecitabine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.6e-05	0.000231	CcSEcCtD
Capecitabine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.6e-05	0.000231	CcSEcCtD
Capecitabine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.58e-05	0.00023	CcSEcCtD
Capecitabine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.58e-05	0.00023	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000229	CcSEcCtD
Capecitabine—Cough—Ramipril—type 2 diabetes mellitus	7.55e-05	0.000229	CcSEcCtD
Capecitabine—Fatigue—Irbesartan—type 2 diabetes mellitus	7.54e-05	0.000229	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.5e-05	0.000228	CcSEcCtD
Capecitabine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.5e-05	0.000228	CcSEcCtD
Capecitabine—Pain—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.000227	CcSEcCtD
Capecitabine—Constipation—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.000227	CcSEcCtD
Capecitabine—Insomnia—Losartan—type 2 diabetes mellitus	7.44e-05	0.000226	CcSEcCtD
Capecitabine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.41e-05	0.000225	CcSEcCtD
Capecitabine—Paraesthesia—Losartan—type 2 diabetes mellitus	7.39e-05	0.000225	CcSEcCtD
Capecitabine—Urticaria—Metformin—type 2 diabetes mellitus	7.36e-05	0.000224	CcSEcCtD
Capecitabine—Chest pain—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000224	CcSEcCtD
Capecitabine—Myalgia—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000224	CcSEcCtD
Capecitabine—Arthralgia—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000224	CcSEcCtD
Capecitabine—Dyspnoea—Losartan—type 2 diabetes mellitus	7.34e-05	0.000223	CcSEcCtD
Capecitabine—Anxiety—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000223	CcSEcCtD
Capecitabine—Nausea—Glyburide—type 2 diabetes mellitus	7.33e-05	0.000223	CcSEcCtD
Capecitabine—Abdominal pain—Metformin—type 2 diabetes mellitus	7.33e-05	0.000223	CcSEcCtD
Capecitabine—Dizziness—Gliclazide—type 2 diabetes mellitus	7.32e-05	0.000223	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.31e-05	0.000222	CcSEcCtD
Capecitabine—Asthenia—Valsartan—type 2 diabetes mellitus	7.3e-05	0.000222	CcSEcCtD
Capecitabine—Discomfort—Ramipril—type 2 diabetes mellitus	7.27e-05	0.000221	CcSEcCtD
Capecitabine—Dyspepsia—Losartan—type 2 diabetes mellitus	7.24e-05	0.00022	CcSEcCtD
Capecitabine—Asthenia—Orlistat—type 2 diabetes mellitus	7.21e-05	0.000219	CcSEcCtD
Capecitabine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000219	CcSEcCtD
Capecitabine—Pruritus—Valsartan—type 2 diabetes mellitus	7.2e-05	0.000219	CcSEcCtD
Capecitabine—Dry mouth—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000219	CcSEcCtD
Capecitabine—Decreased appetite—Losartan—type 2 diabetes mellitus	7.15e-05	0.000217	CcSEcCtD
Capecitabine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000217	CcSEcCtD
Capecitabine—Confusional state—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000216	CcSEcCtD
Capecitabine—Pruritus—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000216	CcSEcCtD
Capecitabine—Fatigue—Losartan—type 2 diabetes mellitus	7.1e-05	0.000216	CcSEcCtD
Capecitabine—Oedema—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000214	CcSEcCtD
Capecitabine—Vomiting—Gliclazide—type 2 diabetes mellitus	7.04e-05	0.000214	CcSEcCtD
Capecitabine—Constipation—Losartan—type 2 diabetes mellitus	7.04e-05	0.000214	CcSEcCtD
Capecitabine—Pain—Losartan—type 2 diabetes mellitus	7.04e-05	0.000214	CcSEcCtD
Capecitabine—Rash—Gliclazide—type 2 diabetes mellitus	6.98e-05	0.000212	CcSEcCtD
Capecitabine—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.98e-05	0.000212	CcSEcCtD
Capecitabine—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.96e-05	0.000212	CcSEcCtD
Capecitabine—Urticaria—Irbesartan—type 2 diabetes mellitus	6.95e-05	0.000211	CcSEcCtD
Capecitabine—Shock—Ramipril—type 2 diabetes mellitus	6.94e-05	0.000211	CcSEcCtD
Capecitabine—Headache—Gliclazide—type 2 diabetes mellitus	6.94e-05	0.000211	CcSEcCtD
Capecitabine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.92e-05	0.00021	CcSEcCtD
Capecitabine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.91e-05	0.00021	CcSEcCtD
Capecitabine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.91e-05	0.00021	CcSEcCtD
Capecitabine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.91e-05	0.00021	CcSEcCtD
Capecitabine—Tachycardia—Ramipril—type 2 diabetes mellitus	6.89e-05	0.000209	CcSEcCtD
Capecitabine—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.88e-05	0.000209	CcSEcCtD
Capecitabine—Skin disorder—Ramipril—type 2 diabetes mellitus	6.85e-05	0.000208	CcSEcCtD
Capecitabine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.82e-05	0.000207	CcSEcCtD
Capecitabine—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.78e-05	0.000206	CcSEcCtD
Capecitabine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.73e-05	0.000204	CcSEcCtD
Capecitabine—Dizziness—Valsartan—type 2 diabetes mellitus	6.73e-05	0.000204	CcSEcCtD
Capecitabine—Anorexia—Ramipril—type 2 diabetes mellitus	6.73e-05	0.000204	CcSEcCtD
Capecitabine—Dizziness—Orlistat—type 2 diabetes mellitus	6.65e-05	0.000202	CcSEcCtD
Capecitabine—Asthenia—Metformin—type 2 diabetes mellitus	6.65e-05	0.000202	CcSEcCtD
Capecitabine—Hypotension—Ramipril—type 2 diabetes mellitus	6.59e-05	0.0002	CcSEcCtD
Capecitabine—Nausea—Gliclazide—type 2 diabetes mellitus	6.58e-05	0.0002	CcSEcCtD
Capecitabine—Pruritus—Metformin—type 2 diabetes mellitus	6.56e-05	0.000199	CcSEcCtD
Capecitabine—Urticaria—Losartan—type 2 diabetes mellitus	6.54e-05	0.000199	CcSEcCtD
Capecitabine—Abdominal pain—Losartan—type 2 diabetes mellitus	6.51e-05	0.000198	CcSEcCtD
Capecitabine—Body temperature increased—Losartan—type 2 diabetes mellitus	6.51e-05	0.000198	CcSEcCtD
Capecitabine—Vomiting—Valsartan—type 2 diabetes mellitus	6.47e-05	0.000197	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	6.44e-05	0.000558	CbGpPWpGaD
Capecitabine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.44e-05	0.000196	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000195	CcSEcCtD
Capecitabine—CDA—Metabolism—GSTM1—type 2 diabetes mellitus	6.43e-05	0.000556	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GCG—type 2 diabetes mellitus	6.43e-05	0.000556	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC2A4—type 2 diabetes mellitus	6.43e-05	0.000556	CbGpPWpGaD
Capecitabine—Rash—Valsartan—type 2 diabetes mellitus	6.42e-05	0.000195	CcSEcCtD
Capecitabine—Dermatitis—Valsartan—type 2 diabetes mellitus	6.41e-05	0.000195	CcSEcCtD
Capecitabine—Vomiting—Orlistat—type 2 diabetes mellitus	6.39e-05	0.000194	CcSEcCtD
Capecitabine—Insomnia—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000194	CcSEcCtD
Capecitabine—Headache—Valsartan—type 2 diabetes mellitus	6.37e-05	0.000194	CcSEcCtD
Capecitabine—DPYD—Metabolism—MTHFR—type 2 diabetes mellitus	6.37e-05	0.000551	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NCOA6—type 2 diabetes mellitus	6.37e-05	0.000551	CbGpPWpGaD
Capecitabine—Diarrhoea—Metformin—type 2 diabetes mellitus	6.34e-05	0.000193	CcSEcCtD
Capecitabine—Rash—Orlistat—type 2 diabetes mellitus	6.34e-05	0.000193	CcSEcCtD
Capecitabine—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.34e-05	0.000193	CcSEcCtD
Capecitabine—Dermatitis—Orlistat—type 2 diabetes mellitus	6.33e-05	0.000192	CcSEcCtD
Capecitabine—CDA—Metabolism—LPL—type 2 diabetes mellitus	6.31e-05	0.000546	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PPP2CA—type 2 diabetes mellitus	6.3e-05	0.000545	CbGpPWpGaD
Capecitabine—Headache—Orlistat—type 2 diabetes mellitus	6.3e-05	0.000191	CcSEcCtD
Capecitabine—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000191	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	6.29e-05	0.000544	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	6.28e-05	0.000543	CbGpPWpGaD
Capecitabine—Asthenia—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000191	CcSEcCtD
Capecitabine—TYMS—Metabolism—UCP3—type 2 diabetes mellitus	6.26e-05	0.000541	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HSD11B1—type 2 diabetes mellitus	6.26e-05	0.000541	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—UCP2—type 2 diabetes mellitus	6.26e-05	0.000541	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PPARA—type 2 diabetes mellitus	6.25e-05	0.000541	CbGpPWpGaD
Capecitabine—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000189	CcSEcCtD
Capecitabine—Pruritus—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000188	CcSEcCtD
Capecitabine—CDA—Metabolism—ADCY5—type 2 diabetes mellitus	6.18e-05	0.000534	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GPX1—type 2 diabetes mellitus	6.15e-05	0.000532	CbGpPWpGaD
Capecitabine—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000186	CcSEcCtD
Capecitabine—Dizziness—Metformin—type 2 diabetes mellitus	6.13e-05	0.000186	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000185	CcSEcCtD
Capecitabine—Fatigue—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000185	CcSEcCtD
Capecitabine—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.06e-05	0.000184	CcSEcCtD
Capecitabine—DPYD—Metabolism—AGT—type 2 diabetes mellitus	6.05e-05	0.000524	CbGpPWpGaD
Capecitabine—Nausea—Valsartan—type 2 diabetes mellitus	6.04e-05	0.000184	CcSEcCtD
Capecitabine—Constipation—Ramipril—type 2 diabetes mellitus	6.03e-05	0.000183	CcSEcCtD
Capecitabine—CDA—Metabolism—CD36—type 2 diabetes mellitus	5.99e-05	0.000519	CbGpPWpGaD
Capecitabine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.000182	CcSEcCtD
Capecitabine—Nausea—Orlistat—type 2 diabetes mellitus	5.97e-05	0.000181	CcSEcCtD
Capecitabine—DPYD—Metabolism—CALM1—type 2 diabetes mellitus	5.95e-05	0.000515	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—APOE—type 2 diabetes mellitus	5.93e-05	0.000513	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PPP2CA—type 2 diabetes mellitus	5.92e-05	0.000512	CbGpPWpGaD
Capecitabine—Asthenia—Losartan—type 2 diabetes mellitus	5.9e-05	0.000179	CcSEcCtD
Capecitabine—Vomiting—Metformin—type 2 diabetes mellitus	5.89e-05	0.000179	CcSEcCtD
Capecitabine—TYMS—Metabolism—PCK1—type 2 diabetes mellitus	5.88e-05	0.000509	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—APOA1—type 2 diabetes mellitus	5.86e-05	0.000507	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP2E1—type 2 diabetes mellitus	5.85e-05	0.000506	CbGpPWpGaD
Capecitabine—Rash—Metformin—type 2 diabetes mellitus	5.84e-05	0.000178	CcSEcCtD
Capecitabine—Dermatitis—Metformin—type 2 diabetes mellitus	5.84e-05	0.000177	CcSEcCtD
Capecitabine—Pruritus—Losartan—type 2 diabetes mellitus	5.82e-05	0.000177	CcSEcCtD
Capecitabine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000177	CcSEcCtD
Capecitabine—Headache—Metformin—type 2 diabetes mellitus	5.81e-05	0.000176	CcSEcCtD
Capecitabine—Dizziness—Irbesartan—type 2 diabetes mellitus	5.78e-05	0.000176	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—CYP1A2—type 2 diabetes mellitus	5.78e-05	0.0005	CbGpPWpGaD
Capecitabine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000175	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	5.77e-05	0.000499	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	5.76e-05	0.000498	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	5.7e-05	0.000493	CbGpPWpGaD
Capecitabine—CDA—Metabolism—MTHFR—type 2 diabetes mellitus	5.68e-05	0.000491	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	5.65e-05	0.000489	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP3A4—type 2 diabetes mellitus	5.64e-05	0.000488	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PPP2CA—type 2 diabetes mellitus	5.63e-05	0.000487	CbGpPWpGaD
Capecitabine—Diarrhoea—Losartan—type 2 diabetes mellitus	5.63e-05	0.000171	CcSEcCtD
Capecitabine—Urticaria—Ramipril—type 2 diabetes mellitus	5.61e-05	0.00017	CcSEcCtD
Capecitabine—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.58e-05	0.00017	CcSEcCtD
Capecitabine—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.58e-05	0.00017	CcSEcCtD
Capecitabine—CDA—Metabolism—PPARA—type 2 diabetes mellitus	5.57e-05	0.000482	CbGpPWpGaD
Capecitabine—Vomiting—Irbesartan—type 2 diabetes mellitus	5.56e-05	0.000169	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	5.56e-05	0.000481	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GNB3—type 2 diabetes mellitus	5.54e-05	0.000479	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.54e-05	0.000479	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—HMOX1—type 2 diabetes mellitus	5.51e-05	0.000477	CbGpPWpGaD
Capecitabine—Rash—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.000168	CcSEcCtD
Capecitabine—TYMS—Metabolism—HK1—type 2 diabetes mellitus	5.51e-05	0.000477	CbGpPWpGaD
Capecitabine—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.000167	CcSEcCtD
Capecitabine—Nausea—Metformin—type 2 diabetes mellitus	5.5e-05	0.000167	CcSEcCtD
Capecitabine—Headache—Irbesartan—type 2 diabetes mellitus	5.48e-05	0.000166	CcSEcCtD
Capecitabine—Dizziness—Losartan—type 2 diabetes mellitus	5.44e-05	0.000165	CcSEcCtD
Capecitabine—TYMP—Metabolism—CAT—type 2 diabetes mellitus	5.44e-05	0.000471	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AGT—type 2 diabetes mellitus	5.4e-05	0.000467	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	5.38e-05	0.000465	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HSD3B2—type 2 diabetes mellitus	5.32e-05	0.00046	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LPA—type 2 diabetes mellitus	5.32e-05	0.00046	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GCKR—type 2 diabetes mellitus	5.32e-05	0.00046	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—KCNJ11—type 2 diabetes mellitus	5.32e-05	0.00046	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	5.31e-05	0.000459	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CALM1—type 2 diabetes mellitus	5.31e-05	0.000459	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APOE—type 2 diabetes mellitus	5.29e-05	0.000457	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APOB—type 2 diabetes mellitus	5.28e-05	0.000457	CbGpPWpGaD
Capecitabine—Vomiting—Losartan—type 2 diabetes mellitus	5.23e-05	0.000159	CcSEcCtD
Capecitabine—CDA—Metabolism—APOA1—type 2 diabetes mellitus	5.23e-05	0.000452	CbGpPWpGaD
Capecitabine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000158	CcSEcCtD
Capecitabine—Nausea—Irbesartan—type 2 diabetes mellitus	5.19e-05	0.000158	CcSEcCtD
Capecitabine—Rash—Losartan—type 2 diabetes mellitus	5.19e-05	0.000158	CcSEcCtD
Capecitabine—Dermatitis—Losartan—type 2 diabetes mellitus	5.18e-05	0.000158	CcSEcCtD
Capecitabine—DPYD—Metabolism—PPARG—type 2 diabetes mellitus	5.17e-05	0.000447	CbGpPWpGaD
Capecitabine—Headache—Losartan—type 2 diabetes mellitus	5.16e-05	0.000157	CcSEcCtD
Capecitabine—TYMP—Metabolism—GSTM1—type 2 diabetes mellitus	5.14e-05	0.000445	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALDOB—type 2 diabetes mellitus	5.1e-05	0.000441	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—INS—type 2 diabetes mellitus	5.07e-05	0.000438	CbGpPWpGaD
Capecitabine—Asthenia—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000154	CcSEcCtD
Capecitabine—TYMP—Metabolism—LPL—type 2 diabetes mellitus	5.04e-05	0.000436	CbGpPWpGaD
Capecitabine—Pruritus—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000152	CcSEcCtD
Capecitabine—TYMP—Metabolism—ADCY5—type 2 diabetes mellitus	4.94e-05	0.000427	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GPX1—type 2 diabetes mellitus	4.92e-05	0.000426	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	4.89e-05	0.000423	CbGpPWpGaD
Capecitabine—Nausea—Losartan—type 2 diabetes mellitus	4.89e-05	0.000149	CcSEcCtD
Capecitabine—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000147	CcSEcCtD
Capecitabine—TYMP—Metabolism—CD36—type 2 diabetes mellitus	4.79e-05	0.000415	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	4.76e-05	0.000412	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PRKCB—type 2 diabetes mellitus	4.75e-05	0.000411	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GLP1R—type 2 diabetes mellitus	4.74e-05	0.00041	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPP2CA—type 2 diabetes mellitus	4.73e-05	0.000409	CbGpPWpGaD
Capecitabine—Dizziness—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000142	CcSEcCtD
Capecitabine—DPYD—Metabolism—ALB—type 2 diabetes mellitus	4.65e-05	0.000402	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PPARG—type 2 diabetes mellitus	4.61e-05	0.000398	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	4.54e-05	0.000393	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	4.54e-05	0.000393	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	4.54e-05	0.000393	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MTHFR—type 2 diabetes mellitus	4.54e-05	0.000393	CbGpPWpGaD
Capecitabine—CDA—Metabolism—INS—type 2 diabetes mellitus	4.52e-05	0.000391	CbGpPWpGaD
Capecitabine—Vomiting—Ramipril—type 2 diabetes mellitus	4.49e-05	0.000136	CcSEcCtD
Capecitabine—TYMP—Metabolism—PPARA—type 2 diabetes mellitus	4.45e-05	0.000385	CbGpPWpGaD
Capecitabine—Rash—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000135	CcSEcCtD
Capecitabine—Dermatitis—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000135	CcSEcCtD
Capecitabine—DPYD—Metabolism—NOS3—type 2 diabetes mellitus	4.44e-05	0.000385	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3R1—type 2 diabetes mellitus	4.44e-05	0.000385	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTM1—type 2 diabetes mellitus	4.43e-05	0.000383	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC2A2—type 2 diabetes mellitus	4.43e-05	0.000383	CbGpPWpGaD
Capecitabine—Headache—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000134	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	4.37e-05	0.000378	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CPT1A—type 2 diabetes mellitus	4.34e-05	0.000375	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTR—type 2 diabetes mellitus	4.34e-05	0.000375	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AGT—type 2 diabetes mellitus	4.31e-05	0.000373	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NAMPT—type 2 diabetes mellitus	4.25e-05	0.000368	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CALM1—type 2 diabetes mellitus	4.24e-05	0.000367	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LIPC—type 2 diabetes mellitus	4.23e-05	0.000366	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GCK—type 2 diabetes mellitus	4.23e-05	0.000366	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HBA1—type 2 diabetes mellitus	4.23e-05	0.000366	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APOE—type 2 diabetes mellitus	4.23e-05	0.000366	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP11A1—type 2 diabetes mellitus	4.2e-05	0.000363	CbGpPWpGaD
Capecitabine—Nausea—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000127	CcSEcCtD
Capecitabine—TYMP—Metabolism—APOA1—type 2 diabetes mellitus	4.18e-05	0.000362	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—IL6—type 2 diabetes mellitus	4.17e-05	0.000361	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALB—type 2 diabetes mellitus	4.14e-05	0.000358	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC9A1—type 2 diabetes mellitus	4.13e-05	0.000357	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	4.13e-05	0.000357	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	4.12e-05	0.000356	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CETP—type 2 diabetes mellitus	4.08e-05	0.000353	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTGS2—type 2 diabetes mellitus	4.06e-05	0.000352	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	4.05e-05	0.00035	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	4e-05	0.000346	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3R1—type 2 diabetes mellitus	3.96e-05	0.000343	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NOS3—type 2 diabetes mellitus	3.96e-05	0.000343	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SREBF1—type 2 diabetes mellitus	3.79e-05	0.000328	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PSMD6—type 2 diabetes mellitus	3.79e-05	0.000328	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SNAP25—type 2 diabetes mellitus	3.79e-05	0.000328	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CTGF—type 2 diabetes mellitus	3.72e-05	0.000322	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HMGCR—type 2 diabetes mellitus	3.69e-05	0.000319	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2A—type 2 diabetes mellitus	3.69e-05	0.000319	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPARG—type 2 diabetes mellitus	3.68e-05	0.000319	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTGS2—type 2 diabetes mellitus	3.62e-05	0.000313	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—INS—type 2 diabetes mellitus	3.61e-05	0.000312	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ADRA2A—type 2 diabetes mellitus	3.61e-05	0.000312	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP2E1—type 2 diabetes mellitus	3.47e-05	0.0003	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	3.44e-05	0.000298	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	3.44e-05	0.000298	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP1A2—type 2 diabetes mellitus	3.43e-05	0.000297	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC2A1—type 2 diabetes mellitus	3.43e-05	0.000297	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—BHMT—type 2 diabetes mellitus	3.38e-05	0.000292	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP3A4—type 2 diabetes mellitus	3.34e-05	0.000289	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALB—type 2 diabetes mellitus	3.31e-05	0.000286	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC2A4—type 2 diabetes mellitus	3.29e-05	0.000284	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GCG—type 2 diabetes mellitus	3.29e-05	0.000284	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NOS3—type 2 diabetes mellitus	3.17e-05	0.000274	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3R1—type 2 diabetes mellitus	3.17e-05	0.000274	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AANAT—type 2 diabetes mellitus	2.95e-05	0.000255	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGDS—type 2 diabetes mellitus	2.95e-05	0.000255	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTGS2—type 2 diabetes mellitus	2.9e-05	0.000251	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GNB3—type 2 diabetes mellitus	2.83e-05	0.000245	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.83e-05	0.000245	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HMOX1—type 2 diabetes mellitus	2.82e-05	0.000244	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	2.81e-05	0.000243	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	2.8e-05	0.000242	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	2.8e-05	0.000242	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CAT—type 2 diabetes mellitus	2.78e-05	0.000241	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.74e-05	0.000237	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.72e-05	0.000235	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOB—type 2 diabetes mellitus	2.7e-05	0.000234	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	2.67e-05	0.000231	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2.64e-05	0.000228	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTM1—type 2 diabetes mellitus	2.63e-05	0.000227	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LPL—type 2 diabetes mellitus	2.58e-05	0.000223	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ADCY5—type 2 diabetes mellitus	2.53e-05	0.000219	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GPX1—type 2 diabetes mellitus	2.52e-05	0.000218	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	2.46e-05	0.000213	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	2.46e-05	0.000213	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.45e-05	0.000212	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CD36—type 2 diabetes mellitus	2.45e-05	0.000212	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPP2CA—type 2 diabetes mellitus	2.42e-05	0.000209	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.41e-05	0.000208	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.39e-05	0.000207	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.38e-05	0.000206	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	2.38e-05	0.000206	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	2.38e-05	0.000206	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	2.38e-05	0.000206	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	2.38e-05	0.000206	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTHFR—type 2 diabetes mellitus	2.32e-05	0.000201	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	2.31e-05	0.000199	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARA—type 2 diabetes mellitus	2.28e-05	0.000197	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.22e-05	0.000192	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AGT—type 2 diabetes mellitus	2.21e-05	0.000191	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	2.18e-05	0.000188	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	2.18e-05	0.000188	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CALM1—type 2 diabetes mellitus	2.17e-05	0.000188	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOE—type 2 diabetes mellitus	2.16e-05	0.000187	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOA1—type 2 diabetes mellitus	2.14e-05	0.000185	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	2.12e-05	0.000184	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKT1—type 2 diabetes mellitus	2.04e-05	0.000177	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	2.02e-05	0.000175	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	2.02e-05	0.000175	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	2.02e-05	0.000175	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.94e-05	0.000168	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.94e-05	0.000168	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARG—type 2 diabetes mellitus	1.88e-05	0.000163	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.87e-05	0.000162	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.87e-05	0.000162	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—INS—type 2 diabetes mellitus	1.85e-05	0.00016	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.83e-05	0.000159	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.83e-05	0.000159	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—type 2 diabetes mellitus	1.82e-05	0.000158	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.8e-05	0.000156	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.8e-05	0.000156	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.8e-05	0.000156	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.75e-05	0.000151	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.7e-05	0.000147	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALB—type 2 diabetes mellitus	1.69e-05	0.000147	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.67e-05	0.000144	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.63e-05	0.000141	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3R1—type 2 diabetes mellitus	1.62e-05	0.00014	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NOS3—type 2 diabetes mellitus	1.62e-05	0.00014	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.59e-05	0.000137	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.59e-05	0.000137	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.53e-05	0.000133	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.53e-05	0.000133	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.53e-05	0.000133	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.53e-05	0.000133	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS2—type 2 diabetes mellitus	1.48e-05	0.000128	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.47e-05	0.000128	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.47e-05	0.000127	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—type 2 diabetes mellitus	1.46e-05	0.000126	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.43e-05	0.000124	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.4e-05	0.000121	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.38e-05	0.00012	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.37e-05	0.000118	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.28e-05	0.00011	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.25e-05	0.000108	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.25e-05	0.000108	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.23e-05	0.000106	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.22e-05	0.000105	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.22e-05	0.000105	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.22e-05	0.000105	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.22e-05	0.000105	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.21e-05	0.000105	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.19e-05	0.000103	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.18e-05	0.000102	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.1e-05	9.48e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.09e-05	9.46e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.09e-05	9.46e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.09e-05	9.46e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.07e-05	9.28e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.06e-05	9.2e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.05e-05	9.07e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.04e-05	9e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1e-05	8.65e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	9.88e-06	8.55e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	9.88e-06	8.55e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	9.64e-06	8.34e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.59e-06	8.3e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	9.48e-06	8.2e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	9.48e-06	8.2e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.17e-06	7.07e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	8.17e-06	7.07e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	8.13e-06	7.03e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	8.02e-06	6.94e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	7.79e-06	6.74e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	7.58e-06	6.55e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—type 2 diabetes mellitus	7.45e-06	6.44e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	7.44e-06	6.43e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	7.28e-06	6.3e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	7.25e-06	6.28e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	7.07e-06	6.11e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	6.98e-06	6.04e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	6.7e-06	5.79e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	6.57e-06	5.68e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	6.36e-06	5.5e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	6.26e-06	5.41e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	6.23e-06	5.39e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.16e-06	5.33e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.43e-06	4.7e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.32e-06	4.61e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	4.88e-06	4.22e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	4.67e-06	4.04e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	4.67e-06	4.04e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.27e-06	3.7e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.15e-06	1.86e-05	CbGpPWpGaD
